About Us

PharmaTher Inc., a wholly-owned subsidiary of Newscope Capital Corporation (CSE: PHRM) (OTCQB: PHRRF), is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals such as ketamine and psilocybin, for FDA approval to treat mental health, neurological and pain disorders.

Corporate Deck (Jan 2021)

Press Releases

January 19, 2021
PharmaTher Signs Exclusive Worldwide License Agreement for Patented Ketamine Formulation Targeting Mental Health, Neurological and Pain Disorders

January 13, 2021
PharmaTher Approved to Trade on the OTCQB Venture Market

December 30, 2020
PharmaTher Announces Application for OTCQB Listing

December 21, 2020
PharmaTher Signs LOI to Sell Psilocybin Program to Revive Therapeutics
​​
...more press releases

CONNECT WITH US